BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 82353)

  • 21. Thymus derived lymphocytes (T cells) in patients with genital warts.
    Mohanty KC; Roy RB
    Br J Vener Dis; 1984 Jun; 60(3):186-8. PubMed ID: 6610454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of cell mediated immunity in patients with genital warts of long duration.
    Avgerinou G; Georgala S; Theodoridis A; Vareltzdis A; Stratigos J
    Genitourin Med; 1986 Dec; 62(6):396-8. PubMed ID: 3817815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A primary clinical trial of genital warts treated with domestic highly purified podophyllotoxin].
    Wang B; Wang B; Shao Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):122-5. PubMed ID: 7987938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological aspects of wart regression with special reference to regression phenomenon of numerous flat warts. An experiment on tumor immunity in man by nature.
    Tagami H; Oguchi M; Ofuji S
    J Dermatol; 1983 Feb; 10(1):1-12. PubMed ID: 6306083
    [No Abstract]   [Full Text] [Related]  

  • 25. Cimetidine treatment for viral warts enhances IL-2 and IFN-gamma expression but not IL-18 expression in lesional skin.
    Mitsuishi T; Iida K; Kawana S
    Eur J Dermatol; 2003; 13(5):445-8. PubMed ID: 14693487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
    Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
    Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dinitrochlorbenzene (DNCB) treatment of viral warts. A 5-year follow-up study.
    Johansson E; Förström L
    Acta Derm Venereol; 1984; 64(6):529-33. PubMed ID: 6084926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wart-associated antigens. I. Isolation of tissue antigens using antibody immunoadsorbents.
    Pass F; Marcus DM
    J Invest Dermatol; 1973 May; 60(5):301-6. PubMed ID: 4357154
    [No Abstract]   [Full Text] [Related]  

  • 29. [New developments relating to papillomaviruses].
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Obalek S; Rzesa G; Croissant O; Favre M
    Hautarzt; 1979 Aug; 30(8):411-7. PubMed ID: 229087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery processes during regression of plane warts.
    Takigawa M; Tagami H; Watanabe S; Ogino A; Imamura S; Ofugi S
    Arch Dermatol; 1977 Sep; 113(9):1214-8. PubMed ID: 900964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological events in regressing genital warts.
    Coleman N; Birley HD; Renton AM; Hanna NF; Ryait BK; Byrne M; Taylor-Robinson D; Stanley MA
    Am J Clin Pathol; 1994 Dec; 102(6):768-74. PubMed ID: 7801889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy.
    Johnson SM; Horn TD
    J Drugs Dermatol; 2004; 3(3):263-5. PubMed ID: 15176159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
    Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
    Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed immune function in epidermodysplasia verruciformis.
    Prawer SE; Pass F; Vance JC; Greenberg LJ; Yunis EJ; Zelickson AS
    Arch Dermatol; 1977 Apr; 113(4):495-9. PubMed ID: 848981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological studies with human papova (wart) virus.
    Ogilvie MM
    J Hyg (Lond); 1970 Sep; 68(3):479-90. PubMed ID: 4318815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo controlled observer blind immunocytochemical and histologic study of epithelium adjacent to anogenital warts in patients treated with systemic interferon alpha in combination with cryotherapy or cryotherapy alone.
    Handley JM; Maw RD; Horner T; Lawther H; Walsh M; Dinsmore WW
    Genitourin Med; 1992 Apr; 68(2):100-5. PubMed ID: 1316307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological studies in a student population prone to infection with human papilloma virus.
    Cubie HA
    J Hyg (Lond); 1972 Dec; 70(4):677-90. PubMed ID: 4346010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative investigation of epidermal markers on cells freshly isolated from from normal and wart epidermis.
    Chardonnet Y; Viac J; Beauve P; Thivolet J
    Arch Dermatol Res; 1984; 276(4):246-9. PubMed ID: 6206806
    [No Abstract]   [Full Text] [Related]  

  • 40. Regression of warts. An immunological study.
    Pyrhönen S; Johansson E
    Lancet; 1975 Mar; 1(7907):592-6. PubMed ID: 47944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.